MedPath

A study to see effect of manjisthadi lepa in treatment of hyperpigmentation.

Phase 1
Registration Number
CTRI/2020/03/023698
Lead Sponsor
Dr Jai Bhawani Babulal Barai
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patient having signs and symptoms of vyanga

Exclusion Criteria

Hyperpigmentation caused by tumour like malingant melanoma.

Patients with secondary systemic involvement.

Vyanga along with kustha roga will be excluded.

Pregnant and lactating women.

Hyperpigmentation caused since birth is excluded because prognosis is very bad in these conditions.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To get cured of Hyperpigmentation.Timepoint: The cure shall be assessed by two follow ups in 30 days.
Secondary Outcome Measures
NameTimeMethod
Getting cured of the marked symptoms on the skin adding to the cosmetic effect.Timepoint: 30 days
© Copyright 2025. All Rights Reserved by MedPath